IBOK
NVO

Independence Bank of Kentucky’s Novo Nordisk NVO Stock Holding History

Independence Bank of Kentucky’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.7K Sell
1,600
-100
-6% -$4.3K 0.01% 366
2026
Q1 		$62.5K Sell
1,700
-2,772
-62% -$131K 0.01% 390
2025
Q4 		$228K Sell
4,472
-763
-15% -$39K 0.03% 274
2025
Q3 		$290K Sell
5,235
-60
-1% -$3.51K 0.04% 253
2025
Q2 		$365K Sell
5,295
-8,965
-63% -$610K 0.05% 227
2025
Q1 		$990K Buy
14,260
+1,070
+8% +$88.4K 0.15% 130
2024
Q4 		$1.13M Buy
13,190
+1,700
+15% +$184K 0.17% 116
2024
Q3 		$1.37M Buy
11,490
+7,565
+193% +$1.01M 0.29% 93
2024
Q2 		$560K Buy
3,925
+1,575
+67% +$209K 0.15% 147
2024
Q1 		$302K Buy
2,350
+225
+11% +$26.8K 0.09% 186
2023
Q4 		$220K Buy
2,125
+1,875
+750% +$185K 0.08% 194
2023
Q3 		$22.7K Buy
250
+50
+25% +$4.41K 0.01% 343
2023
Q2 		$16.2K Hold
200
– – 0.01% 360
2023
Q1 		$15.9K Hold
200
– – 0.01% 334
2022
Q4 		$14K Hold
200
– – 0.01% 341
2022
Q3 		$10K Hold
200
– – ﹤0.01% 342
2022
Q2 		$11K Hold
200
– – ﹤0.01% 338
2022
Q1 		$11K Hold
200
– – ﹤0.01% 344
2021
Q4 		$11K Hold
200
– – ﹤0.01% 335
2021
Q3 		$10K Hold
200
– – ﹤0.01% 341
2021
Q2 		$8K Hold
200
– – ﹤0.01% 349
2021
Q1 		$7K Hold
200
– – ﹤0.01% 349
2020
Q4 		$7K Hold
200
– – ﹤0.01% 339
2020
Q3 		$7K Hold
200
– – ﹤0.01% 321
2020
Q2 		$7K Hold
200
– – ﹤0.01% 299
2020
Q1 		$6K Hold
200
– – ﹤0.01% 307
2019
Q4 		$6K Buy
+200
New +$5.54K ﹤0.01% 322

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Independence Bank of Kentucky's NVO Position: Q2 2026 in Review

Independence Bank of Kentucky reduced its Novo Nordisk (NVO) stake by 5.9% in Q2 2026, selling an estimated $4.3K and leaving 1,600 shares worth $76.7K. The position accounts for 0.01% of the portfolio, ranked #366.

Independence Bank of Kentucky first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.37M in Q3 2024. 756 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Independence Bank of Kentucky held 1,600 shares of Novo Nordisk worth $76.7K as of Q2 2026.
  • Independence Bank of Kentucky sold 100 Novo Nordisk shares in Q2 2026, an estimated $4.3K.
  • Novo Nordisk made up 0.01% of Independence Bank of Kentucky's portfolio in Q2 2026, its #366 holding.
  • Independence Bank of Kentucky first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
  • Independence Bank of Kentucky's Novo Nordisk position peaked at $1.37M in Q3 2024.
  • 756 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.